activins has been researched along with Cancer of Liver in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (20.00) | 18.2507 |
| 2000's | 8 (32.00) | 29.6817 |
| 2010's | 7 (28.00) | 24.3611 |
| 2020's | 5 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, L; Guo, J; Jiang, Z; Peng, H; Yang, X; Ye, T | 1 |
| Buechler, C; Mester, P; Treeck, O; Weber, F | 1 |
| Dai, G; Hamang, M; Yaden, B | 1 |
| Chen, C; Guan, S; Hu, D; Lin, R; Ruan, Q; Yang, C; Yu, H; Zhang, H; Zhuo, C | 1 |
| Hanahan, D; Michael, IP; Saghafinia, S | 1 |
| Chen, J; Chen, Y; Ding, Z; Dong, L; Huang, Z; Kang, Z; Qian, B; Sun, X; Zang, Y; Zhang, J | 1 |
| Baek, JY; Hong, DS; Hong, S; Hong, YS; Hwang, IG; Jang, JS; Kim, HJ; Kim, JH; Kim, JW; Kim, SH; Kim, TY; Lee, JH; Shin, SH; Sun, S; Woo, IS | 1 |
| Han, Z; Lv, M; Mi, X; Shi, Y; Zhang, H; Zhang, W | 1 |
| Frost, K; Grasl-Kraupp, B; Grusch, M; Lackner, A; Rodgarkia-Dara, C; Schulte-Hermann, R; Seir, K | 1 |
| Matsuzaki, K | 1 |
| Georgiadou, M; Klironomos, S; Koulentaki, M; Kouroumalis, E; Notas, G; Voumvouraki, A | 1 |
| Filik, L | 1 |
| Chabicovsky, M; Grasl-Kraupp, B; Peter, B; Rossmanith, W; Schausberger, E; Schulte-Hermann, R | 1 |
| Benckert, C; Peters, M; Rosewicz, S; Ruderisch, HS; Scholz, A; Wagner, K; Wiedenmann, B | 1 |
| Abaza, MM; Amin, GM; Elsammak, MY; Khalil, GM; Ragab, WS | 1 |
| Liu, ZH; Ma, D; Tai, GX; Zhang, HJ; Zhou, J | 1 |
| Berger, W; Deli, A; Grusch, M; Kreidl, E; Rodgarkia-Dara, C; Santifaller, S; Schulte-Hermann, R; Seir, K; Trotter, B | 1 |
| Kanzaki, M; Kojima, I; Mashima, H; Mine, T; Nobusawa, R; Suzuki, M; Zhang, YQ | 1 |
| Matsuzaki, K; McKeehan, K; McKeehan, WL; Xu, J | 1 |
| Kan, M; Krummen, L; Matsuzaki, K; McKeehan, WL; Wang, F; Xu, J | 1 |
| Brauman, JN; de Kretser, DM; Hedger, MP; Phillips, DJ; Russell, CE | 1 |
| Ichikawa, Y; Ishikawa, T; Lebrun, JJ; Mitsuhashi, M; Momiyama, N; Nagashima, Y; Shimada, H; Takabe, K; Vale, WW | 1 |
| Hashimoto, O; Hayakawa, T; Hyuga, M; Hyuga, S; Kawasaki, N; Ohta, M; Yamagata, S; Yamagata, T | 1 |
| Branca, B; Del Forno, M; Fabris, C; Federico, E; Luisi, S; Mattiuzzo, M; Petraglia, F; Pirisi, M; Santuz, M; Toniutto, P; Vitulli, D | 1 |
| Evans, LW; Hughes, RD; Langley, PG; Norris, S; Yuen, MF | 1 |
4 review(s) available for activins and Cancer of Liver
| Article | Year |
|---|---|
Expression and Function of BMP and Activin Membrane-Bound Inhibitor (BAMBI) in Chronic Liver Diseases and Hepatocellular Carcinoma.
Topics: Activins; Bone Morphogenetic Proteins; Carcinoma, Hepatocellular; Humans; Liver Cirrhosis; Liver Neoplasms; Membrane Proteins; Transforming Growth Factor beta | 2023 |
Gastrointestinal pharmacology activins in liver health and disease.
Topics: Activin Receptors; Activins; Animals; Carcinoma, Hepatocellular; Follistatin; Liver Neoplasms; Mammals; Mice | 2023 |
Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cells.
Topics: Activins; Animals; Carcinoma, Hepatocellular; Epithelial Cells; Humans; JNK Mitogen-Activated Protein Kinases; Liver; Liver Diseases; Liver Neoplasms; Mesoderm; Phosphorylation; Protein Isoforms; Signal Transduction; Smad Proteins | 2012 |
Activins and activin antagonists in hepatocellular carcinoma.
Topics: Activins; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Humans; Inhibins; Liver Neoplasms; Models, Molecular; Protein Conformation; Protein Subunits; Signal Transduction; Smad Proteins | 2008 |
21 other study(ies) available for activins and Cancer of Liver
| Article | Year |
|---|---|
Sequential Treatment with Activin and Hepatocyte Growth Factor Induces FOXM1 to Promote Colorectal Cancer Liver Metastasis.
Topics: Activins; alpha-Fetoproteins; Colorectal Neoplasms; Forkhead Box Protein M1; Hepatocyte Growth Factor; Humans; Liver Neoplasms; Up-Regulation | 2022 |
Activin A/ACVR2A axis inhibits epithelial-to-mesenchymal transition in colon cancer by activating SMAD2.
Topics: Activins; Animals; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Epithelial-Mesenchymal Transition; Humans; Liver Neoplasms; Mice; Smad2 Protein | 2023 |
A set of microRNAs coordinately controls tumorigenesis, invasion, and metastasis.
Topics: Activin Receptors, Type I; Activins; Algorithms; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Computational Biology; Doxycycline; Gene Expression Regulation, Neoplastic; Humans; LDL-Receptor Related Proteins; Liver Neoplasms; Membrane Transport Proteins; Mice; MicroRNAs; Neuroendocrine Tumors; Pancreatic Neoplasms; Prognosis; Receptors, LDL; Xenograft Model Antitumor Assays | 2019 |
Sox9/INHBB axis-mediated crosstalk between the hepatoma and hepatic stellate cells promotes the metastasis of hepatocellular carcinoma.
Topics: Activins; Animals; Carcinoma, Hepatocellular; Cell Proliferation; Disease Progression; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Hep G2 Cells; Hepatic Stellate Cells; Humans; Inhibin-beta Subunits; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Mice; Paracrine Communication; Signal Transduction; Smad Proteins; SOX9 Transcription Factor; Tumor Microenvironment; Up-Regulation; Xenograft Model Antitumor Assays | 2021 |
Serum biomarkers for predicting overall survival and early mortality in older patients with metastatic solid tumors.
Topics: Activins; Aged; Aged, 80 and over; Antineoplastic Agents; Biliary Tract Neoplasms; Biomarkers; C-Reactive Protein; Chemokine CXCL10; Collagen Type I; Colonic Neoplasms; Decision Trees; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibronectins; Humans; Interleukin-6; Liver Neoplasms; Lung Neoplasms; Male; Mortality; Myostatin; Neoplasm Metastasis; Neoplasms; Peptides; Prognosis; Republic of Korea; Sirtuin 1; Stomach Neoplasms; Survival Rate; Vascular Endothelial Growth Factor A; Vitamin D | 2019 |
HBx interacted with Smad4 to deprive activin a growth inhibition function in hepatocyte HL7702 on CRM1 manner.
Topics: Active Transport, Cell Nucleus; Activins; Cell Proliferation; Cells, Cultured; Exportin 1 Protein; Hepatocytes; Humans; Karyopherins; Liver Neoplasms; Receptors, Cytoplasmic and Nuclear; Smad4 Protein; Trans-Activators; Viral Regulatory and Accessory Proteins | 2016 |
Inhibin/activin expression in human and rodent liver: subunits α and βB as new players in human hepatocellular carcinoma?
Topics: Activins; Adult; Aged; Animals; Carcinoma, Hepatocellular; Case-Control Studies; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Inhibins; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Middle Aged; Protein Subunits; Rats; Rats, Wistar; Rodentia | 2011 |
Increased serum activin-A differentiates alcoholic from cirrhosis of other aetiologies.
Topics: Activins; Adult; Aged; Carcinoma, Hepatocellular; Female; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Neoplasms; Male; Middle Aged | 2012 |
Activin as a promising test in differential diagnosis of chronic liver diseases.
Topics: Activins; Carcinoma, Hepatocellular; Female; Hepatitis C, Chronic; Humans; Liver Cirrhosis, Alcoholic; Liver Neoplasms; Male | 2012 |
Follistatin overexpression in rodent liver tumors: a possible mechanism to overcome activin growth control.
Topics: Activins; Adenoma; Alternative Splicing; Animals; Blotting, Western; Carcinoma, Hepatocellular; Cell Division; Diethylnitrosamine; Follistatin; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred Strains; Nafenopin; Phenobarbital; Rats; Reference Values; RNA, Messenger; Transforming Growth Factor alpha; Tumor Cells, Cultured | 2002 |
Activin A stimulates vascular endothelial growth factor gene transcription in human hepatocellular carcinoma cells.
Topics: Activin Receptors; Activins; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA-Binding Proteins; Gene Expression; Humans; Inhibin-beta Subunits; Liver Neoplasms; Neovascularization, Pathologic; Promoter Regions, Genetic; Smad2 Protein; Sp1 Transcription Factor; Sp3 Transcription Factor; Trans-Activators; Transcription Factors; Transcription, Genetic; Vascular Endothelial Growth Factor A | 2004 |
Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
Topics: Activins; Adult; Carcinoma, Hepatocellular; Egypt; Female; Hepatitis C; Humans; Inhibin-beta Subunits; Insulin-Like Growth Factor I; Liver Neoplasms; Male; Middle Aged; Schistosomiasis | 2006 |
Regulation of activin receptor-interacting protein 2 expression in mouse hepatoma Hepa1-6 cells and its relationship with collagen type IV.
Topics: Activin Receptors, Type II; Activins; Adaptor Proteins, Signal Transducing; Adenylyl Cyclases; Animals; Calcimycin; Calcium; Carcinoma, Hepatocellular; Cell Line, Tumor; Colforsin; Collagen Type IV; Enzyme Activators; Gene Expression Regulation, Neoplastic; Ionophores; Kinetics; Lipopolysaccharides; Liver Neoplasms; Membrane Proteins; Mice; Protein Kinase C; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate; Transfection | 2007 |
Derangements in the activin-follistatin system in hepatoma cells.
Topics: Activins; Base Sequence; Carcinoma, Hepatocellular; Cell Division; DNA, Neoplasm; Follistatin; Glycoproteins; Growth Substances; Humans; Inhibins; Liver Neoplasms; Molecular Probes; Molecular Sequence Data; Tumor Cells, Cultured | 1995 |
Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism.
Topics: Activin Receptors; Activins; Amino Acid Sequence; Animals; Baculoviridae; Base Sequence; Binding, Competitive; Carcinoma, Hepatocellular; Cell Division; Cell Membrane; DNA Primers; Growth Substances; Humans; Inhibins; Kinetics; Liver Neoplasms; Models, Biological; Molecular Sequence Data; Polymerase Chain Reaction; Protein Serine-Threonine Kinases; Receptors, Growth Factor; Recombinant Proteins; Spodoptera; Transfection; Tumor Cells, Cultured | 1995 |
A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic factor.
Topics: Activins; Amino Acid Sequence; Animals; Base Sequence; Bone Morphogenetic Proteins; Carcinoma, Hepatocellular; Cell Line; Cloning, Molecular; DNA, Neoplasm; Gene Expression; Growth Substances; Humans; Inhibins; Liver; Liver Neoplasms; Molecular Sequence Data; Moths; Oligodeoxyribonucleotides; Polymerase Chain Reaction; Protein Serine-Threonine Kinases; Proteins; RNA, Neoplasm; Sequence Homology, Amino Acid; Substrate Specificity; Transfection; Transforming Growth Factor beta; Tumor Cells, Cultured | 1993 |
Activin A regulates growth and acute phase proteins in the human liver cell line, HepG2.
Topics: Activins; Acute-Phase Proteins; Carcinoma, Hepatocellular; Cell Division; Dose-Response Relationship, Drug; Follistatin; Glycoproteins; Growth Substances; Haptoglobins; Humans; Inflammation; Inhibins; Interleukin-1; Interleukin-6; Kinetics; Liver Neoplasms; Orosomucoid; Recombinant Proteins; Tumor Cells, Cultured | 1999 |
Interruption of activin A autocrine regulation by antisense oligodeoxynucleotides accelerates liver tumor cell proliferation.
Topics: Activins; Autocrine Communication; Cell Division; Humans; Inhibins; Liver Neoplasms; Oligonucleotides, Antisense; Transforming Growth Factor beta; Tumor Cells, Cultured | 1999 |
Possible role of hepatocyte growth factor/scatter factor and activin A produced by the target organ in liver metastasis.
Topics: Activin Receptors, Type I; Activins; Animals; Cell Division; Cell Movement; Hepatocyte Growth Factor; Inhibins; Liver Neoplasms; Mice; Mice, Inbred BALB C; Proto-Oncogene Proteins c-met; Receptors, Growth Factor; Tumor Cells, Cultured | 2000 |
Evaluation of circulating activin-A as a serum marker of hepatocellular carcinoma.
Topics: Activins; Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Aspartate Aminotransferases; Biomarkers; Carcinoma, Hepatocellular; Female; Humans; Inhibins; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Peptides; Prostatic Secretory Proteins; RNA, Messenger | 2000 |
Transforming growth factor-beta 1, activin and follistatin in patients with hepatocellular carcinoma and patients with alcoholic cirrhosis.
Topics: Activins; Apoptosis; Carcinoma, Hepatocellular; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Follistatin; Humans; Liver Cirrhosis, Alcoholic; Liver Neoplasms; Male; Middle Aged; Transforming Growth Factor beta | 2002 |